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Abstract
Background: Accurate estimation of gestational age is important for both clinical and public health purposes.
Estimates of gestational age using fetal ultrasound measurements are considered most accurate but are frequently
unavailable in low- and middle-income countries. The objective of this study was to assess the validity of last
menstrual period and Farr neonatal examination estimates of gestational age, compared to ultrasound estimates, in
a large cohort of women in Vietnam.
Methods: Data for this analysis come from a randomized, placebo-controlled micronutrient supplementation trial in
Vietnam. We analyzed 912 women with ultrasound and prospectively-collected last menstrual period estimates of
gestational age and 685 women with ultrasound and Farr estimates of gestational age. We used the Wilcoxon
signed rank sum test to assess differences in gestational age estimated by last menstrual period or Farr examination
compared to ultrasound and computed the intraclass correlation coefficient (ICC) and concordance correlation
coefficient (CCC) to quantify agreement between methods. We computed the Kappa coefficient (κ) to quantify
agreement in preterm, term and post-term classification.
Results: The median gestational age estimated by ultrasound was 273.9 days. Gestational age was slightly overestimated
by last menstrual period (median 276.0 days, P < 0.001) and more greatly overestimated by Farr examination (median 286.
7 days, P < 0.001). Gestational age estimates by last menstrual period and ultrasound were moderately correlated
(ICC = 0.78) and concordant (CCC = 0.63), whereas gestational age estimates by Farr examination and ultrasound
were weakly correlated (ICC = 0.26) and concordant (CCC = 0.05). Last menstrual period and ultrasound estimates of
gestational age were within ± 14 days for 88.4% of women; Farr and ultrasound estimates were within ± 14 days for 55.
8% of women. Last menstrual period and ultrasound estimates of gestational age had higher agreement in term
classification (κ = 0.41) than Farr and ultrasound (κ = 0.05).
Conclusion: In this study of women in Vietnam, we found last menstrual period provided a more accurate estimate of
gestational age than the Farr examination when compared to ultrasound. These findings provide useful information
about the utility and accuracy of different methods to estimate gestational age and suggest last menstrual period may
be preferred over Farr examination in settings where ultrasound is unavailable.
Trial registration: The trial was registered at ClinicalTrials.Gov as NCT01665378 on August 13, 2012.
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Background
Accurate estimates of gestational age (GA) are important
for both clinical practice and public health activities.
Clinically, estimates of GA identify infants at risk for ad-
verse health outcomes because GA is a proxy for fetal
development and is associated with infant survival [1].
Public health indicators, such as proportion of preterm
birth, rely on accurate estimates of GA to monitor popu-
lation health, identify subgroups requiring intervention
and evaluate public health programs [2].
Conceptually, GA refers to the duration of time be-
tween conception and delivery; because the timing of
conception cannot be easily ascertained, GA is com-
monly estimated as the difference between the first day
of the last menstrual period (LMP) and the delivery date
[2]. Last menstrual period estimates of GA assume that
the menstrual cycle occurs regularly and lasts 28 days,
and that ovulation occurs on the 14th day with concep-
tion occurring shortly thereafter; however, these assump-
tions may not apply to all women. Estimates of GA
based on LMP are widely used because this information
is easy and inexpensive to collect, but women may be
unable to recall their LMP or may misreport their LMP
due to mid-cycle bleeding or occasional bleeding during
pregnancy [3]. Furthermore, the accuracy of LMP may
decrease as recall length increases [4]. Women who are
younger, primiparous, or have lower education are more
likely to misreport LMP [3, 5] and in low- and middle-
income settings, where educational attainment tends to
be lower [6], it is possible that recall errors seriously in-
fluence the accuracy of reported LMP.
In settings where LMP may be biased, neonatal exami-
nations may be used to estimate GA [3]. Neonatal exam-
inations assess physical and/or neuromuscular maturity
of newborn infants using standardized scoring methods
and convert scores to estimates of GA; unlike LMP esti-
mates of GA, neonatal examinations do not directly
measure pregnancy duration. Neonatal examinations are
typically used in clinical settings and rely on well-trained
health care professionals to examine infants. Gestational
age estimates from neonatal examinations have been
found to be less accurate and reliable than other
methods and estimates may vary by race/ethnicity [3, 7].
Furthermore, examinations that assess both physical and
neuromuscular characteristics may be complex for clini-
cians and stressful for newborns, which may limit their
utility [8].
Recently, it has become common to estimate GA using
ultrasound measurements of fetal biometry; this is done
by relating biometry measurements to GA through re-
gression equations. First trimester measurements of
crown-rump length provide the most accurate estimates
of GA, with an estimated error of ± 5–7 days [9]. Accur-
acy of ultrasound estimates of GA decreases in the
second trimester, with estimated error of ±10–14 days
due to increased variability in fetal biometry [9]. Ultra-
sound estimates of GA are limited because actual preg-
nancy duration is not measured and this method
assumes all variation in fetal size is attributable to GA,
which does not account for normal variability [3].
Despite these limitations, first or second trimester ultra-
sound estimates of GA have been found to be more
accurate when predicting delivery date compared to
LMP-based estimates [3, 9–11].
In low- and middle-income settings, ultrasound esti-
mates of GA are frequently not feasible due to limited
resources or delayed entry into prenatal care [12]; thus,
it is necessary to evaluate less expensive and more prac-
tical methods to estimate GA. To date, few studies have
assessed estimates of GA based on LMP and neonatal
examination compared to ultrasound in low- and
middle-income countries. A study in Bangladesh con-
cluded LMP was a more reliable method than neonatal
examinations but findings were limited to infants youn-
ger than 33 weeks gestation [13]. A study in Guatemala
found similar results, but was limited by a small sample
size [14]. The objective of this study was to assess the
validity of LMP and neonatal examination estimates of
GA compared to ultrasound estimates in a large cohort
of women in Vietnam.
Methods
Data for this analysis (Additional file 1) come from the
PRECONCEPT trial, a double-blind, randomized trial in-
vestigating the effects of pre-conceptual micronutrient sup-
plementation on maternal and child outcomes in the Thai
Nguyen province of Vietnam [15]. The PRECONCEPT trial
is a collaboration between Emory University in the USA
and the Thai Nguyen University of Medicine and Pharmacy
in Vietnam and was approved by the Ethical Committee of
Institute of Social and Medicine Studies in Vietnam and
Emory University’s Institutional Review Board.
Women of reproductive age were enrolled into the
PRECONCEPT trial if they were currently married,
intended to remain in the study area, planned to have a
child within one year but were not currently pregnant,
did not regularly consume micronutrient supplements
or did not have a history of high-risk pregnancy [15]. At
enrollment, participants provided informed consent, and
baseline demographic and anthropometric data were
collected. Specifically, height was measured using a port-
able stadiometer and weight was measured using an
electronic Seca scale; measurements were completed in
duplicate and followed standard procedures [16, 17]. At
enrollment, women were randomized into treatment
groups and received biweekly supplements by village
health workers who also monitored pregnancy status.
Pregnancy was confirmed at local Commune Health
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Centers and women who conceived during the study
period from 2012 to 2014 received prenatal care through
the existing health system and were followed up for
pregnancy outcomes. Information at delivery, including
infant birth weight and length, were collected by study
nurses or physicians. Infant weight was measured within
7 days of delivery using a UNICEF beam-type scale. Re-
cumbent length at birth was measured using a wooden
measurement board. Measurements were completed in
duplicate [16, 17].
We estimated GA at delivery using three methods:
LMP, the Farr neonatal examination (referred to as
‘Farr’) and ultrasound. The first day of the LMP was ob-
tained prospectively by village health workers during bi-
weekly home visits to distribute supplements and
monitor pregnancy status. If LMP was reported five or
more weeks prior to the visit, pregnancy status was
confirmed and information on LMP was transferred to
clinic staff to estimate GA. LMP estimates of GA at de-
livery were calculated by subtracting a woman’s LMP
from her delivery date.
The Farr examination was used to estimate GA in the
PRECONCEPT trial because it assesses only physical
characteristics and is more practical than neonatal ex-
aminations that include neuromuscular assessments.
The Farr examination scores 12 characteristics of phys-
ical maturity: skin texture, skin color, skin opacity,
edema, lanugo, skull hardness, ear form, ear firmness,
genitalia, breast size, nipple formation and plantar skin
creases [18]. Each characteristic is scored from 0 to 4,
with a higher score indicating advanced maturity; scores
are summed and converted to weeks of completed gesta-
tion by equations developed by Farr and colleagues [19].
Study doctors or nurses completed Farr examinations at
district hospitals within 24 h of birth.
We considered ultrasound estimates of GA as the gold
standard method because previous validation studies
have consistently found ultrasound estimates of GA to
be more accurate than other methods [3, 9–11]. We cal-
culated ultrasound estimates of GA in several steps.
First, fetal femur length and head circumference were
measured in replicate by trained study doctors using a
portable ultrasound machine (Prosound 2, Hitachi Aloka
Japan); if duplicate measurements differed by more than
4 mm for femur length (FL) or 10 mm for head circum-
ference (HC), a third measurement was taken and the
average of the two closest measurements were used for
analysis. Next, GA on the day of the measurements was
calculated using a regression equation recently published
by Papageorghiou and colleagues [20]. Briefly, this
equation was developed using second trimester fetal
biometry measurements from a single ultrasound exam-
ination among women with certain LMP dates in the
INTERGROWTH-21st project. A machine learning
approach was used to generate candidate equations re-
lating combinations of fetal biometry variables (including
head circumference, femur length, occipitofrontal diam-
eter, abdominal circumference, and biparietal diameter
measurements) to GA. A final equation was selected
based upon minimization of prediction error, goodness
of fit and model complexity. The final model that pro-
vided the best estimates of GA included fetal head cir-
cumference and femur length measurements; inclusion
of additional fetal biometric measures did not improve
prediction of GA. The regression equation relating head
circumference and femur length to GA is as follows:
loge GAð Þ ¼ 0:03243  loge HCð Þ
 2 þ 0:001644
 FL  loge HCð Þ þ 3:813
Gestational age at delivery was estimated by adding
the difference between the delivery date and the date of
ultrasound measurement to the estimated GA on the
day of ultrasound.
Overall, 5011 women were eligible and agreed to par-
ticipate in the PRECONCEPT trial (Fig. 1); of those,
2384 women did not conceive during the trial period
and 814 withdrew from the trial before conceiving,
resulting in 1813 pregnancies. A total of 1619 women
gave birth to a live born, singleton infant, and we re-
stricted our sample to 927 women with available second
trimester (13–28 week) ultrasound (Fig. 1). To maximize
sample size, two subsamples were created: i) 923 women
with second trimester ultrasound and LMP estimates of
GA and ii) 693 women with second trimester ultrasound
and Farr estimates of GA. Women with LMP (n = 11) or
Farr estimates (n = 8) of GA that differed from ultra-
sound estimates by more than six weeks were considered
outliers and excluded from analysis. Our final subsample
sizes were 912 women for the LMP analysis and 685
women for the Farr analysis.
We examined the validity of LMP and Farr examin-
ation estimates of GA compared to ultrasound estimates
(considered gold standard) in several ways. We used the
median and interquartile range to describe the distribu-
tion of GA estimated by each method and the Wilcoxon
signed rank sum test to assess statistically significant dif-
ferences between methods because GA distributions es-
timated by LMP, Farr and ultrasound were slightly
skewed. We also quantified the difference between
methods using the mean difference (LMP – ultrasound
or Farr – ultrasound) because the distribution of the dif-
ferences followed an approximately normal distribution.
The intra-class correlation coefficient (ICC) was used to
estimate consistency between methods and was com-
puted using a two-way, random effects analysis of
variance model; a higher ICC indicates a higher degree
of consistency [21, 22]. We used the concordance
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correlation coefficient (CCC) to quantify the absolute
agreement between two methods; it is visualized as the
degree in which measurements from two methods fall
on a line that intersects the origin at 45° (the line of per-
fect concordance). A CCC of 1 indicates perfect con-
cordance [23]. Finally, we used the Kappa coefficient to
examine the agreement adjusted for chance in classifica-
tion of preterm (<259 days), term (259–294 days) and
post-term (>294 days) births between LMP or Farr esti-
mates of GA compared to ultrasound.
To visually examine our data, we plotted the distribu-
tions of GA estimated by LMP or Farr compared to
ultrasound using Bland-Altman plots. The difference be-
tween GA estimation methods (LMP – ultrasound or
Farr – ultrasound) varied across average GA; therefore,
we used a regression approach to determine the mean
difference as a function of average GA and to determine
the 95% Limits of Agreement; the Limits of Agreement
may be interpreted as the range where 95% of differ-
ences are expected to occur [24].
We conducted a sensitivity analysis to examine the
validity of LMP and Farr examination estimates of GA,
compared to ultrasound estimates, separately for males
and females. Statistical analyses were conducted using
SAS version 9.3 (SAS Institute, Cary, NC). P < 0.05 was
considered statistically significant.
Results
Maternal and infant characteristics for 912 women with
ultrasound and LMP estimates of GA are shown in
Table 1; characteristics were similar for 685 women with
ultrasound and Farr estimates of GA (data not shown).
On average, women were 28 years old and 30.8% had a
body mass index (BMI; kg/m2) below 18.5. One-half of
infants were male and, on average, infants were 49 cm
long at birth and 5% were classified as low-birth-weight
(<2500 g). We found no significant differences in mater-
nal or infant characteristics between women included
and excluded in the analysis (data not shown).
The GA distributions estimated by LMP and Farr
compared to ultrasound are displayed in Fig. 2a and b,
respectively. Generally, the GA distributions estimated
by LMP and ultrasound appeared similar and overlap,
although LMP slightly overestimate GA. The GA
Fig. 1 Flow chart describing sample of eligible women and women included in analysis from PRECONCEPT trial
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distribution estimated by Farr appeared narrower than that
estimated by ultrasound and also appeared to overestimate
GA. These trends are confirmed in the Bland-Altman plots
for LMP compared to ultrasound and Farr compared to
ultrasound in Fig. 3a and b, respectively. Specifically, com-
pared to ultrasound, LMP underestimated GA for infants
born earlier and overestimated GA for infants born later
(Fig. 3a); the Farr method frequently overestimated GA, es-
pecially for infants born earlier (Fig. 3b).
The agreement between GA estimation methods is
presented in Table 2. The median GA estimated by
ultrasound was approximately 274 days. The median GA
estimated by LMP and Farr were approximately 276 and
287 days, respectively, and were significantly greater
than GA estimated by ultrasound (p < 0.001). On aver-
age, compared to ultrasound, LMP overestimated GA by
1.4 days (95% CI: 0.7–2.0) whereas Farr overestimated
by 12.9 days (95% CI: 12.2–13.5). The LMP and
ultrasound estimates of GA were moderately correlated
(ICC = 0.78, 95% CI: 0.74–0.80) and moderately con-
cordant (CCC = 0.63, 95%CI: 0.59–0.67). In contrast, the
Farr estimate was weakly correlated with ultrasound esti-
mate (ICC = 0.26, 95% CI: 0.15–0.37) and showed low con-
cordance (CCC = 0.05, 95% CI: 0.04–0.07). Last menstrual
period and ultrasound estimates of GA were within ± 7 days
for nearly 69% of women and within ± 14 days for approxi-
mately 88% of women (Table 2). Farr and ultrasound
estimates of GA were within ± 7 and ±14 days for approxi-
mately 24% and 56% of women, respectively (Table 2).
Table 3 depicts the agreement in the classification of
preterm, term and post-term infants estimated by LMP
or Farr methods compared to ultrasound. Compared
with ultrasound estimates of GA, LMP classified slightly
more infants as preterm (9.3% vs 7.5%) and post-term
(2.6% vs 0.5%); Farr estimates classified almost all infants
as term (99.9%) and did not classify any infants as post-
term. Overall, LMP and ultrasound had higher agree-
ment in term classification (κ = 0.41, p < 0.001) than Farr
and ultrasound (κ = 0.05, p < 0.001).
In sensitivity analyses examining estimates of GA for
males and females separately, we found no substantial dif-
ferences in estimates by gender, nor did estimates substan-
tially differ from aggregate results (data not shown).
Discussion
This was one of the few studies that examined the valid-
ity of LMP and neonatal examination estimates of GA
compared to ultrasound in a low- and middle-income
country. Overall, we found LMP provided a better
Table 1 Maternal and infant characteristics of the study sample
(n = 912)
Characteristic Mean (SD) or n (%)
Maternal age (years) 27.6 (4.3)
Maternal pre-pregnant weight (kg) 45.7 (5.3)
Maternal height (cm) 152.7 (5.0)
Maternal pre-pregnancy BMI (kg/m2) 19.6 (2.0)




≥ 2 11 (1.4)
Sex of infant (Male) 457 (50.1)
Birthweight (g) 3098.3 (457.5)
Birth length (cm) 49.0 (3.1)
Low birthweight (<2500 g) 45 (5.0)
High birthweight (>3500 g) 123 (13.6)
aTotal may not add to 912 due to individuals with missing information
Fig. 2 Distribution of gestational age (GA) estimated by last menstrual period (LMP), Farr examination and ultrasound measurements (US).
a Distribution of GA estimated by LMP (gray) and US (black). b Distribution of GA estimated by Farr examination (white) and US (black)
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estimate of GA than the Farr examination. Compared to
ultrasound, LMP overestimated mean GA by 1.4 days
while the Farr examination overestimated mean GA by
12.9 days. In addition, over 88% of women had LMP and
ultrasound estimates of GA within ± 14 days compared to
56% with Farr and ultrasound estimates within ± 14 days.
LMP and ultrasound estimates of GA also had higher cor-
relation, concordance and agreement in term status than
did Farr compared to ultrasound estimates of GA.
Our finding that LMP more accurately estimated GA
than neonatal examinations is consistent with findings
from a study in Guatemala, which found no significant
difference in mean GA estimated by ultrasound or LMP
and found 94% of women had ultrasound and LMP esti-
mates of GA within ± 14 days. Neonatal examination in
the Guatemala study underestimated mean GA by over
3 days and 82% of women had neonatal examination
and ultrasound estimates of GA within ± 14 days [14].
Notably, LMP was ascertained prospectively in both the
Guatemala study and in our study, which likely mini-
mized recall bias and improved the performance of LMP
estimates of GA.
Results from the Guatemala study suggest LMP and
neonatal examination were more valid in that setting than
was observed in our study; this may be due to the greater
extent of intrauterine growth restriction (IUGR) in our
study population and different neonatal examinations
used in each study. Findings from a recent study by our
group indicate a pattern of IUGR among women
participating in the PRECONCEPT trial, which began in
mid-pregnancy and continued through delivery [25].
Ultrasound measurements completed earlier in pregnancy
are also less likely influenced by IUGR [10]; in our study,
measurements were completed before 28 weeks while in
Fig. 3 Bland-Altman plots depicting difference between (a) last menstrual period (LMP) and ultrasound estimates of gestational age or (b) Farr
examination and ultrasound estimates of gestational age, plotted against the average of the two methods. Solid line indicates mean difference and
dotted line indicates Bland-Altman 95% Limits of Agreement (LOA). Positive y-values indicate overestimation by (a) LMP estimates or (b) Farr estimates
compared to ultrasound







273.9 (268.2, 279.3) 276.0a (268.0, 282.0) 286.7a (286.7, 288.6)
Mean difference (days) (95% CI) Reference 1.4 (0.7, 2.0) 12.9 (12.2, 13.5)
Intra-class correlation coefficient (95% CI) Reference 0.78 (0.74, 0.80) 0.26 (0.15, 0.37)
Concordance correlation coefficient (95% CI) Reference 0.63 (0.59, 0.67) 0.05 (0.04, 0.07)
Agreement with ultrasound n (%)
±7 days Reference 625 (68.5) 166 (24.2)
±10 days Reference 731 (80.2) 254 (37.1)
±14 days Reference 806 (88.4) 382 (55.8)
aP < 0.001
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the Guatemala study, all measurements were completed
before 24 weeks. Taken together, ultrasound estimates of
GA in our study were more likely to be influenced by
IUGR, which would underestimate GA and may bias our
results. Moreover, estimates of GA by neonatal examin-
ation may vary by race/ethnicity and may explain differ-
ences in validity observed in our study and the Guatemala
study [7]. Studies in other low- and middle income coun-
tries have also found the Farr examination to be less ac-
curate than other neonatal examinations [26].
In addition to improved accuracy over neonatal exami-
nations, LMP estimates of GA may be preferred because
healthcare professionals can prioritize care for mothers
and newborns rather than conduct the neonatal examin-
ation. Indeed, one study in Bangladesh found LMP esti-
mates of GA were slightly less correlated and concordant
with ultrasound than two neonatal examination methods;
nevertheless, the authors conclude LMP was valid and
clinically preferred to estimate GA in a low-resource set-
ting [13]. Measurement of the symphysis-fundal height is
an alternate method that may be used to estimate GA dur-
ing pregnancy, but there is inconsistent evidence whether
symphysis-fundal height performs better than LMP in
low- and middle income countries [27].
Our study is strengthened by a large sample size, which
allowed us to detect a mean difference of less than 2 days
between LMP and ultrasound estimates of GA and
allowed us to conclude that that LMP is a reasonable al-
ternative to US estimates of GA in our study and possibly
other low- and middle-income settings. Ultrasound esti-
mates of GA were calculated from equations recently de-
veloped using a machine learning algorithm to identify
the best set of fetal biometric predictors of GA [20]. Fur-
ther, dating equations were derived using data from the
INTERGROWTH-21st Project, which utilized a large,
multi-site, population-based design with strict quality
control measures to ensure internal validity [28]. Finally,
our measure of LMP was assessed prospectively and
likely reduced recall errors; however, this may not repre-
sent usual circumstances in other low- and middle-
income countries. Our study also has some limitations.
Specifically, we are limited by the timing of fetal ultra-
sound measurements. First trimester ultrasound mea-
surements are optimal when estimating GA because of
limited variability in fetal size due to IUGR [3]; ultra-
sound estimates in our study are likely influenced by
IUGR, which would underestimate GA and may bias re-
sults. In low- and middle-income countries, however,
first trimester ultrasound measurements are typically not
feasible and previous studies have demonstrated the ac-
curacy of second trimester ultrasound estimates of GA
[29]. Despite being considered gold standard, it is im-
portant to recognize that ultrasound estimates of GA are
not direct measurements of pregnancy duration and,
similar to other GA estimation methods, are subject to
some error [3]; importantly, studies have established the
improved accuracy of ultrasound estimates of GA com-
pared with other methods [3, 9–11].
Conclusion
LMP estimates of GA performed better than Farr examin-
ation when compared to ultrasound in a population of
Southeast Asian women. As ultrasound measurements are
frequently not available in low- and middle-income coun-
tries, it is important to identify alternative methods that
provide accurate estimates of GA. Our findings provide
information regarding the utility of LMP-based estimates
of GA compared to Farr examination estimates, and the
level of accuracy compared to ultrasound estimates.
Additional file
Additional file 1: Analytic Dataset. (XLSX 123 kb)
Table 3 Agreement in preterm, term and post-term classification by last menstrual period (LMP) or Farr examination estimates of
gestational age compared to ultrasound estimates









Crude % agreement Kappa statistic
Preterm 41 (4.5) 44 (4.8) 0 (0.0) 85 (9.3) 89.0 0.41a
Term 27 (3.0) 770 (84.4) 4 (0.4) 801 (87.8)
Post-term 0 (0.0) 25 (2.7) 1 (0.1) 26 (2.6)
Total 68 (7.5) 839 (92.0) 5 (0.5) 912
Farr classification
Preterm 1 (0.2) 0 (0.0) 0 (0.0) 1 (0.2) 94.5 0.05a
Term 35 (5.1) 646 (94.3) 3 (0.4) 684 (99.9)
Post-term 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Total 36 (5.3) 646 (92.3) 3 (0.4) 685
aP < 0.001
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